Latest filing published 01 May 2026 for Vericel Corp.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +32.3%Entry US$330.00 · Close at T+365 US$436.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Heidi Hagen: trading record in brief
Heidi Hagen (board member) discloses dealings in 2 companies, chiefly Vericel Corp and Alaunos Therapeutics, Inc. We count 19 filings; the first trade dates from 31 December 2019 and the latest from 29 April 2026.
On the open market, the record shows 1 purchase worth €35k and 2 sales worth €849k. Taken together, the sales exceed the purchases by €813k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants and 14 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 1 May 2026 came the latest disclosure, an option exercise in Vericel Corp. The clock since the last published purchase (3 September 2021) now reads 1,893 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Heidi Hagen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,200 sharesCommon StockSEC:0001140361-26-018543:0
- 15,000 shares@ US$32.4142.9% of flowCommon StockSEC:0001140361-26-011091:1
- 15,000 shares@ US$2.7640.1% of flowCommon StockSEC:0001140361-26-011091:0
- 3,200 sharesCommon StockSEC:0001140361-25-017118:0
- 9,000 shares@ US$49.5343.7% of flowCommon StockSEC:0001140361-25-007181:1
- 9,000 shares@ US$3.7436.2% of flowCommon StockSEC:0001140361-25-007181:0
- 6,000 shares@ US$3.742.1% of flowCommon StockSEC:0001140361-24-043798:1
- 4,000 shares@ US$3.7415.5% of flowCommon StockSEC:0001140361-24-043798:0
- 3,200 sharesCommon StockSEC:0001140361-24-024331:0
- 2,600 sharesCommon StockSEC:0001140361-23-021498:0
- 2,600 sharesCommon StockSEC:0001593968-22-000888:0
- 23,770 shares@ US$1.76100.0% of flowCommon StockSEC:0001209191-21-054829:0Canonical exit: 1 Dec 2021 (T+90)
- 3,000 shares@ US$4.129.2% of flowCommon StockSEC:0001593968-21-001389:1
- 2,250 shares@ US$6.0010.0% of flowCommon StockSEC:0001593968-21-001389:2
- 1,500 shares@ US$6.008.3% of flowCommon StockSEC:0001593968-21-001389:0
- 1,750 sharesCommon StockSEC:0001593968-21-001209:0
- 90,000 shares0Common StockSEC:0001209191-21-018629:0
- 1,750 shares0Common StockSEC:0001593968-20-001088:0
- 31,780 shares0Common StockSEC:0001209191-20-001175:0
19 of 19 declarations
